| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Maia Biotechnology, Inc. (MAIA) has 9 insiders with recent SEC Form 4 filings, including 16 buys and 0 sells. MAIA is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Dir | 1.52M | $2.16M | - | |
| CEO | 976.1K | $1.39M | - | |
| Other | 60.0K | $85.2K | - | |
| Other | 46.5K | $66.0K | - | |
| Dir | 29.8K | $42.3K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Feb 17, 2023 | Luput Cristian | Director | Buy | 134 | $4.24 | $568.74 | - | -45.5% | -65.6% | |
| Feb 16, 2023 | Vitoc Vlad | Chief Executive Officer | Buy | 20 | $4.25 | $85.00 | - | -44.7% | -64.3% | |
| Feb 15, 2023 | Luput Cristian | Director | Buy | 24 | $4.25 | $102.00 | - | -45.7% | -63.7% | |
| Feb 15, 2023 | Smith Stan | Director | Buy | 208 | $4.25 | $884.00 | - | -45.7% | -63.7% | |
| Feb 10, 2023 | Vitoc Vlad | Chief Executive Officer | Buy | 343 | $4.24 | $1,454.32 | - | -42.3% | -66.5% | |
| Feb 10, 2023 | Smith Stan | Director | Buy | 337 | $4.25 | $1,432.25 | - | -42.3% | -66.5% | |
| Jan 26, 2023 | Smith Stan | Director | Buy | 236 | $4.24 | $1,000.73 | - | -46.2% | -67.7% | |
| Jan 13, 2023 | Luput Cristian | Director | Buy | 504 | $3.88 | $1,955.52 | +0.2% | -9.5% | -72.4% | |
| Jan 4, 2023 | Vitoc Vlad | Chief Executive Officer | Buy | 1,266 | $3.68 | $4,658.88 | +0.2% | -1.7% | -66.7% | |
| Jan 3, 2023 | Vitoc Vlad | Chief Executive Officer | Buy | 2,734 | $3.62 | $9,894.36 | +0.2% | +0.8% | -67.5% |